30.05.2012 - Norway's Pronova BioPharma , which supplies the omega-3 heart medicine Lovaza to GlaxoSmithKline, has defeated a U.S. patent challenge from two generics companies. The victory over...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)